CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $701,882 | +227783.8% | 91,013 | +545.5% | 0.11% | +261.3% |
| Q4 2022 | $308 | -99.9% | 14,100 | +8.5% | 0.03% | +34.8% |
| Q3 2022 | $350,000 | +35.7% | 13,000 | -7.1% | 0.02% | +76.9% |
| Q2 2022 | $258,000 | +12.2% | 14,000 | +7.7% | 0.01% | +30.0% |
| Q1 2022 | $230,000 | +115.0% | 13,000 | -15.6% | 0.01% | +233.3% |
| Q2 2021 | $107,000 | -81.3% | 15,400 | -73.9% | 0.00% | -82.4% |
| Q4 2020 | $573,000 | +87.3% | 59,104 | -47.8% | 0.02% | +13.3% |
| Q3 2020 | $306,000 | +1600.0% | 113,300 | +876.7% | 0.02% | +1400.0% |
| Q1 2020 | $18,000 | -21.7% | 11,600 | -88.4% | 0.00% | -50.0% |
| Q3 2019 | $23,000 | – | 100,000 | +900.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -100.0% | 10,000 | -97.4% | 0.00% | -100.0% |
| Q1 2014 | $2,101,000 | – | 390,100 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |